Fagron completed the acquisition of HiperScan from HTGF.

Fagron, a pharmaceutical compounding company, completed the acquisition of HiperScan, a provider of reliable raw material identification in pharmacies, from HTGF, a seed investor. Financial terms were not disclosed. "HTGF invested shortly after our foundation to help bring the scanning grating technology developed at the Fraunhofer IPMS in Dresden to market maturity. We then gradually evolved from a technology provider to an established industry solution provider that is now considered the gold standard in German pharmacies. As part of Fagron, we can now also contribute to accelerating the future of personalizing medicine," Alexander Wolter, HiperScan Managing Director.